首页> 美国卫生研究院文献>BMC Veterinary Research >Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters
【2h】

Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters

机译:在两种不同的疏螺旋体疫苗中重组OspA的免疫应答及其与功能参数的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPrevention of Lyme disease in dogs in North America depends on effective vaccination against infection by the tick vector-born spirochete Borrelia burgdorferi. Most vaccines effectively prevent spirochete transmission to dogs during tick feeding based on immunization with the outer-surface lipoprotein A (OspA) of B. burgdorferi. More recently, vaccines containing additional OspC protein moieties have been introduced. These are designed to enhance protection by forming a second line of defense within the vertebrate host, where OspC expression replaces OspA as the dominant surface antigen. However, supportive data for demonstration of OspC mediated protection is still lacking. Since OspA immunogenicity is of paramount importance to protection against spirochete transmission; this study was designed to compare the immunogenicity of two commercially available vaccines against the Borrelia burgdorferi OspA. We further characterized OspA antigen fractions of these vaccines with respect to their biochemical and biophysical properties.
机译:背景技术北美犬的莱姆病的预防取决于有效的疫苗接种,以预防由出生于壁虱媒介的螺旋体伯氏疏螺旋体伯氏疏螺旋体感染。大多数疫苗基于用伯氏疏螺旋体的外表面脂蛋白A(OspA)进行免疫而有效地防止tick喂养期间螺旋体向狗的传播。最近,已经引入了含有其他OspC蛋白部分的疫苗。通过在脊椎动物宿主内形成第二道防线来增强保护作用,其中OspC表达取代OspA作为优势表面抗原。但是,仍然缺乏用于证明OspC介导的保护的支持性数据。由于OspA的免疫原性对于防止螺旋体传播至关重要。本研究旨在比较两种市售疫苗对伯氏疏螺旋体OspA的免疫原性。我们进一步表征了这些疫苗的OspA抗原级分的生化和生物物理特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号